A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: The PREMET study by Shennan et al. [5]

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 113, Issue 7, 2006, Pages 850-851

  Lamont, R F ^a   Dragovic, B ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; METRONIDAZOLE;

BACTERIAL COLONIZATION; BACTERIAL FLORA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HIGH RISK PREGNANCY; HUMAN; LETTER; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; TISSUE INJURY; UTERINE CERVIX;

ANTI-INFECTIVE AGENTS; BIOLOGICAL MARKERS; FEMALE; FIBRONECTINS; GLYCOPROTEINS; HUMANS; METRONIDAZOLE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIALS;

EID: 33745505362     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2006.00958.x     Document Type: Letter

References (4)

1. Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG 2006 113 : 65 74.
2. Lamont RF. Can antibiotics prevent preterm birth - the pro and con debate. BJOG 2005 112 (Suppl 1 67 73.
3. Lamont RF, Duncan SLB, Mandal D, Bassett P. Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet Gynecol 2003 101 : 516 22.
4. Kiss H, Petricevic L, Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ 2004 329 : 371.